Lung cancer: progress with prognosis and the changing state of play

被引:5
作者
Brims, Fraser J. [1 ,2 ]
McWilliams, Annette [3 ]
Harden, Susan V. [4 ]
O'Byrne, Ken [5 ,6 ]
机构
[1] Sir Charles Gairdner Hosp, Perth, WA, Australia
[2] Curtin Univ, Perth, WA, Australia
[3] Fiona Stanley Hosp, Perth, WA, Australia
[4] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[5] Queensland Univ Technol, Brisbane, Qld, Australia
[6] Princess Alexandra Hosp, Brisbane, Qld, Australia
关键词
CANCER; RADIOTHERAPY;
D O I
10.5694/mja2.51474
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:334 / 336
页数:3
相关论文
共 24 条
[1]   Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC [J].
Antonia, S. J. ;
Villegas, A. ;
Daniel, D. ;
Vicente, D. ;
Murakami, S. ;
Hui, R. ;
Kurata, T. ;
Chiappori, A. ;
Lee, K. H. ;
de Wit, M. ;
Cho, B. C. ;
Bourhaba, M. ;
Quantin, X. ;
Tokito, T. ;
Mekhail, T. ;
Planchard, D. ;
Kim, Y. -C. ;
Karapetis, C. S. ;
Hiret, S. ;
Ostoros, G. ;
Kubota, K. ;
Gray, J. E. ;
Paz-Ares, L. ;
Carpeno, J. de Castro ;
Faivre-Finn, C. ;
Reck, M. ;
Vansteenkiste, J. ;
Spigel, D. R. ;
Wadsworth, C. ;
Melillo, G. ;
Taboada, M. ;
Dennis, P. A. ;
Ozguroglu, M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (24) :2342-2350
[2]   Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial [J].
Ball, David ;
Mai, G. Tao ;
Vinod, Shalini ;
Babington, Scott ;
Ruben, Jeremy ;
Kron, Tomas ;
Chesson, Brent ;
Herschtal, Alan ;
Vanevski, Marijana ;
Rezo, Angela ;
Elder, Christine ;
Skala, Marketa ;
Wirth, Andrew ;
Wheeler, Greg ;
Lim, Adeline ;
Shaw, Mark ;
Schofield, Penelope ;
Irving, Louis ;
Solomon, Benjamin .
LANCET ONCOLOGY, 2019, 20 (04) :494-503
[3]   Global Epidemiology of Lung Cancer [J].
Barta, Julie A. ;
Powell, Charles A. ;
Wisnivesky, Juan P. .
ANNALS OF GLOBAL HEALTH, 2019, 85 (01)
[4]   Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study [J].
Bradley, Jeffrey D. ;
Paulus, Rebecca ;
Komaki, Ritsuko ;
Masters, Gregory ;
Blumenschein, George ;
Schild, Steven ;
Bogart, Jeffrey ;
Hu, Chen ;
Forster, Kenneth ;
Magliocco, Anthony ;
Kavadi, Vivek ;
Garces, Yolanda I. ;
Narayan, Samir ;
Iyengar, Puneeth ;
Robinson, Cliff ;
Wynn, Raymond B. ;
Koprowski, Christopher ;
Meng, Joanne ;
Beitler, Jonathan ;
Gaur, Rakesh ;
Curran, Walter, Jr. ;
Choy, Hak .
LANCET ONCOLOGY, 2015, 16 (02) :187-199
[5]   Variations in lung cancer care and outcomes: How best to identify and improve standards of care? [J].
Brims, Fraser ;
Leong, Tracy ;
Stone, Emily ;
Harden, Susan ;
Marshall, Henry ;
Navani, Neal ;
Stirling, Rob .
RESPIROLOGY, 2021, 26 (12) :1103-1105
[6]   Hospital-based multidisciplinary lung cancer care in Australia: a survey of the landscape in 2021 [J].
Brims, Fraser J. H. ;
Kumarasamy, Chellan ;
Nash, Jessica ;
Leong, Tracy L. ;
Stone, Emily ;
Marshall, Henry M. .
BMJ OPEN RESPIRATORY RESEARCH, 2022, 9 (01)
[7]  
Cancer Australia, NAT CANC STAG DIAGN
[8]  
Cancer Australia, Lung cancer in Australia statistics 2019
[9]  
Cancer Australia, REP LUNG CANC SCREEN
[10]   Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial [J].
Chun, Stephen G. ;
Hu, Chen ;
Choy, Hak ;
Komaki, Ritsuko U. ;
Timmerman, Robert D. ;
Schild, Steven E. ;
Bogart, Jeffrey A. ;
Dobelbower, Michael C. ;
Bosch, Walter ;
Galvin, James M. ;
Kavadi, Vivek S. ;
Narayan, Samir ;
Iyengar, Puneeth ;
Robinson, Clifford G. ;
Wynn, Raymond B. ;
Raben, Adam ;
Augspurger, Mark E. ;
MacRae, RobertM. ;
Paulus, Rebecca ;
Bradley, Jeffrey D. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (01) :56-+